<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Dehydroabietic acid derivative QC4 can be prepared from methyl 7-oxodehydroabietate, phenylhydrazine hydrochloride, 1,2-dibromoethane and 
 <italic class="italic">N</italic>-methyl piperazine, according to 
 <xref ref-type="scheme" rid="molecules-24-01651-sch038" class="xref">Scheme 38</xref> [
 <xref rid="B141-molecules-24-01651" ref-type="bibr" class="xref">141</xref>,
 <xref rid="B150-molecules-24-01651" ref-type="bibr" class="xref">150</xref>]. It shows antimicrobial properties [
 <xref rid="B150-molecules-24-01651" ref-type="bibr" class="xref">150</xref>] and, moreover, induces gastric cancer cell death via oncosis and apoptosis [
 <xref rid="B151-molecules-24-01651" ref-type="bibr" class="xref">151</xref>]. Another dehydroabietic acid derivative QC2 is reported to be able to inhibit skin cancer cell lines [
 <xref rid="B203-molecules-24-01651" ref-type="bibr" class="xref">203</xref>].
</p>
